Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Tarney

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Journal of Obstetrics and Gynecology|May 9, 2024
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparitiesNicholas W Bateman, Tamara Abulez, Christopher M Tarney, et al.
Iscience|January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestryNicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
Gynecologic Oncology|April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trialsZachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Journal of Obstetrics and Gynecology|May 9, 2024
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparitiesNicholas W Bateman, Tamara Abulez, Christopher M Tarney, et al.
Iscience|January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestryNicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
Gynecologic Oncology|April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trialsZachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Pageof 4